Brief: United Laboratories International China Approves United Laboratories' Tadalafil Tablets (5Mg, 10Mg, 20Mg) For Marketing
02/07/2026 11:19
BRIEF-United Laboratories International China Approves United Laboratories' Tadalafil Tablets (5Mg, 10Mg, 20Mg) For Marketing July 2 (Reuters) - United Laboratories International Holdings Ltd 3933.HK:
CHINA APPROVES UNITED LABORATORIES' TADALAFIL TABLETS (5MG, 10MG, 20MG) FOR MARKETING
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million